ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NEPH Nephros Inc

2.20
-0.13 (-5.58%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Nephros Inc NASDAQ:NEPH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.13 -5.58% 2.20 2.20 2.55 2.35 2.21 2.35 14,201 01:00:00

Nephros to Present at Zooming with LD

13/07/2020 12:30pm

GlobeNewswire Inc.


Nephros (NASDAQ:NEPH)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Nephros Charts.

via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will be presenting virtually at the upcoming Zooming with LD event on Thursday, July 23rd at 11:00 AM ET. Daron Evans, President & CEO and Andy Astor, COO & CFO of Nephros will be giving the presentation and answering questions from investors.

Investors and other individuals may access the virtual presentation by registering here: https://calendly.com/ldmicromeetings/nephrospresentation, and clicking on July 23rd to receive the Zoom link.

About Nephros

Nephros is a commercial-stage company that develops and markets high performance water purification products and pathogen detection systems for medical and commercial markets.

Nephros ultrafilters are used in hospitals, medical clinics, and commercial facilities to retain bacteria and viruses from water, providing barriers that aid in infection control for showers, sinks, and ice machines. Nephros ultrafilters are also used in dialysis centers to aid in the removal of endotoxins and other biological contaminants from water and bicarbonate concentrate in hemodialysis machines. 

Nephros pathogen detection systems, including the PluraPath™, SequaPath™, and DialyPath™ systems, provide data on water-borne biological content to medical and water quality professionals. Our products integrate Nephros ultrafilters with quantitative polymerase chain reaction (qPCR) technology to deliver actionable water pathogen information in real time.

Nephros commercial filters, including AETHER™ brand filters, improve the taste and odor of water, and reduce scale build-up in downstream equipment. Nephros and AETHER™ products are used in the health care, food service, hospitality, and convenience store markets.

For more information about Nephros, please visit its website at www.nephros.com.

Contacts:

Investor Relations: Kirin Smith, President PCG Advisory, Inc. (646) 863-6519 ksmith@pcgadvisory.com www.pcgadvisory.com

Media Relations: Bill Douglass Gotham Communications, LLC (646) 504-0890 bill@gothamcomm.com www.gothamcomm.com

Company: Andy Astor, COO & CFO Nephros, Inc. (201) 345-0824 andy@nephros.com www.nephros.com

1 Year Nephros Chart

1 Year Nephros Chart

1 Month Nephros Chart

1 Month Nephros Chart

Your Recent History

Delayed Upgrade Clock